ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 24 filers reported holding ANI PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $31,000 | -11.4% | 29,000 | 0.0% | 0.00% | – |
| Q2 2019 | $35,000 | +12.9% | 29,000 | 0.0% | 0.00% | – |
| Q1 2019 | $31,000 | +6.9% | 29,000 | 0.0% | 0.00% | – |
| Q4 2018 | $29,000 | -3.3% | 29,000 | 0.0% | 0.00% | – |
| Q3 2018 | $30,000 | -9.1% | 29,000 | 0.0% | 0.00% | – |
| Q2 2018 | $33,000 | +6.5% | 29,000 | 0.0% | 0.00% | – |
| Q1 2018 | $31,000 | -6.1% | 29,000 | 0.0% | 0.00% | – |
| Q4 2017 | $33,000 | – | 29,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellesley Asset Management | 67,426 | $72,904,000 | 3.95% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 10,000,000 | $10,763,000 | 0.84% |
| Perceptive Advisors | 7,500,000 | $8,121,000 | 0.56% |
| SCHOLTZ & COMPANY, LLC | 350,000 | $378,000 | 0.39% |
| WOLVERINE ASSET MANAGEMENT LLC | 15,211,000 | $16,535,000 | 0.25% |
| Investors Capital Advisory Services | 422,000 | $454,000 | 0.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 2,042,000 | $2,224,000 | 0.04% |
| Sonora Investment Management, LLC | 40,000 | $43,477,000 | 0.01% |
| ZAZOVE ASSOCIATES LLC | 200,000 | $217,000 | 0.01% |
| GABELLI FUNDS LLC | 1,500,000 | $1,631,000 | 0.01% |